Making “Access” A Meaningful Part of Every Conversation about Psychedelic Therapy​

Psychedelic Therapies: From Approvals to Access

PharmaTher Holdings Submits FDA Meeting Package to Discuss Phase 3 Program...

Small Pharma Announces Update on Intellectual Property Portfolio with Two New...

Numinus Receives Clinical Trial Application Approval from Health Canada for Experiential...

PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to...

Psyence and Eden Labs Announce Extraction and Product Development Collaboration

Silo Pharma Announces Stock Repurchase Program

FDA Grants Ehave Consent to Proceed With Its Clinical Study on...

Apex Labs Granted Approval for 294 Patient Take Home Psilocybin Clinical...

Load more